dalteparin has been researched along with Acute Lymphoid Leukemia in 6 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Children with acute lymphoblastic leukemia (ALL) have a substantial risk for thromboembolism (TE) that is related to L-asparaginase-induced antithrombin (AT) deficiency and placement of central venous lines." | 2.73 | Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia. ( Hager, J; Klein-Franke, A; Kropshofer, G; Meister, B; Strasak, AM; Streif, W, 2008) |
| "Forty-one consecutive children with acute lymphoblastic leukemia (ALL) received prophylaxis therapy with the low molecular weight heparin (LMWH) enoxaparin during L-asparaginase treatment." | 2.70 | Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia. ( Ben Barak, A; Brenner, B; Elhasid, R; Lanir, N; Levin, C; Postovsky, S; Sharon, R; Weyl Ben Arush, M, 2001) |
| "Eighteen patients were found to have a genetic predisposition for TE, all of them received prophylactic LMWH." | 1.36 | Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment. ( Ben Arush, MW; Brenner, B; Elhasid, R; Harlev, D; Sarig, G; Zaidman, I, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazzoleni, S | 1 |
| Putti, MC | 1 |
| Simioni, P | 1 |
| Sainati, L | 1 |
| Tormene, D | 1 |
| Manara, R | 1 |
| Carli, M | 1 |
| Malhotra, P | 1 |
| Jain, S | 1 |
| Kapoor, G | 1 |
| Mitchell, L | 1 |
| Lambers, M | 1 |
| Flege, S | 1 |
| Kenet, G | 1 |
| Li-Thiao-Te, V | 1 |
| Holzhauer, S | 1 |
| Bidlingmaier, C | 1 |
| Frühwald, MC | 1 |
| Heller, C | 1 |
| Schmidt, W | 1 |
| Pautard, B | 1 |
| Nowak-Göttl, U | 1 |
| Harlev, D | 1 |
| Zaidman, I | 1 |
| Sarig, G | 1 |
| Ben Arush, MW | 1 |
| Brenner, B | 2 |
| Elhasid, R | 2 |
| Meister, B | 1 |
| Kropshofer, G | 1 |
| Klein-Franke, A | 1 |
| Strasak, AM | 1 |
| Hager, J | 1 |
| Streif, W | 1 |
| Lanir, N | 1 |
| Sharon, R | 1 |
| Weyl Ben Arush, M | 1 |
| Levin, C | 1 |
| Postovsky, S | 1 |
| Ben Barak, A | 1 |
2 trials available for dalteparin and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
Topics: Adolescent; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparagin | 2008 |
Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia.
Topics: Adolescent; Anticoagulants; Antineoplastic Agents; Asparaginase; Blood Coagulation Factors; Child; C | 2001 |
4 other studies available for dalteparin and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Early cerebral sinovenous thrombosis in a child with acute lymphoblastic leukemia carrying the prothrombin G20210A variant: a case report and review of the literature.
Topics: Activated Protein C Resistance; Amino Acid Substitution; Brain; Child, Preschool; Fibrinolytic Agent | 2005 |
Symptomatic Cerebral Sinovenous Thrombosis Associated With L-Asparaginase In Children With Acute Lymphoblastic Leukemia: A Single Institution Experience Over 17 Years.
Topics: Adolescent; Anticoagulants; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Enoxaparin | 2018 |
Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study.
Topics: Adolescent; Anticoagulants; Asparaginase; Catheterization, Central Venous; Child; Child, Preschool; | 2010 |
Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment.
Topics: Adolescent; Anticoagulants; Asparaginase; Child; Child, Preschool; Enoxaparin; Female; Genetic Predi | 2010 |